The Lakers’ late-season push took a sharp turn when two of their most important perimeter scorers got hurt in the same game.
According to ESPN reporting from April 5 to 7, Luka Dončić traveled to Spain for an injection intended to help heal the Grade 2 left hamstring strain he suffered April 2 against the Oklahoma City Thunder. Austin Reaves, injured in that same game, was diagnosed with a Grade 2 left oblique strain that is expected to sideline him for four to six weeks, a timeline that likely keeps him out for at least the opening round of the playoffs.
That is the immediate news. The larger story is what it does to the Lakers’ playoff structure.
Los Angeles is not dealing with a minor rotation issue here. Dončić and Reaves were not just starters who happened to get hurt at the wrong time. They were central to how the Lakers created offense next to LeBron James. The source material notes that Reaves has averaged 23.3 points, 5.5 assists and 4.7 rebounds in 51 games this season, production that made him far more than a complementary scorer. Dončić, meanwhile, is the kind of player opponents game-plan around before a series even starts.
When both are unavailable, or when one returns at something less than full strength, the Lakers’ offense changes in a very practical way: fewer creators, fewer clean late-clock options, and more possessions that have to be manufactured rather than naturally flowing from star gravity.
Why the Dončić update matters beyond the headline
An injured star traveling to Europe for treatment naturally grabs attention, but the important detail is not the flight. It is the urgency.
ESPN reported that the injection was meant to accelerate Dončić’s return. That tells you how narrow the calendar has become. A Grade 2 hamstring strain is not the sort of injury teams casually push through, especially in April, when every decision is judged against playoff availability rather than regular-season convenience. The Lakers are trying to buy time without openly saying so.
There is a difference between being cleared to play and being ready to carry playoff usage. That distinction matters here. Even if the treatment helps Dončić get back on the floor sooner, the Lakers still need him to move, decelerate, and absorb playoff-level defensive attention without turning a short absence into a longer one. Hamstrings are especially unforgiving when a player relies on bursts, stops, and changes of pace.
That makes this less a simple injury update than a question of how much of Dončić the Lakers can reasonably expect when the games become most demanding.
Reaves’ injury may be the quieter problem, but not the smaller one
Reaves’ Grade 2 oblique strain landed with less spectacle, but its effect on the Lakers could be just as disruptive.
The source makes clear that he is expected to miss four to six weeks and likely at least the first round. For a team losing creation on the perimeter, that matters immediately. Reaves has become the kind of player who stabilizes second units, attacks tilted defenses, and keeps an offense alive when stars sit or defenses load up. Those are playoff possessions, not bookkeeping possessions.
There is also a tactical issue. Oblique injuries affect more than scoring totals. They can interfere with twisting, absorbing contact, and generating force on drives and passes. Even after a player returns, comfort can lag behind clearance. The Lakers are not just waiting on games missed; they may also be waiting on rhythm and physical confidence.
A concrete example helps. Imagine a tight first-round game in which a defense traps James high and shades extra help toward Dončić or, if he is out, simply loads up on every primary action. Normally, Reaves is the player who can catch the second-side advantage, get downhill, and turn a scrambling defense into points or free throws. Without him, that same possession is more likely to end with a reset, a tougher isolation, or a lower-quality shot late in the clock. Over one night, that is manageable. Over a playoff series, it becomes a structural weakness.
The public dispute adds another layer
There is also an unusual sideshow attached to the Reaves injury.
ESPN reported that the Dallas Mavericks publicly disputed Lakers coach JJ Redick’s claim that their medical staff had scanned the wrong area during Reaves’ initial MRI. Dallas said its protocols were followed. That does not change Reaves’ diagnosis, but it does change the temperature around it.
Public disagreements over medical handling are rarely useful in the middle of a playoff race. At best, they create noise around an already difficult recovery timeline. At worst, they invite outside focus onto process questions that neither team benefits from litigating in public.
For readers trying to sort signal from noise, the practical takeaway is simple: the dispute is notable, but the real issue is still availability. The Lakers’ postseason chances will be shaped by how much basketball Dončić and Reaves can play, not by which side wins a public argument about imaging protocol.
What this changes for the Lakers
The source notes that the Lakers entered this stretch at 50-27 and had made a run to the Pacific Division title. That is exactly why these injuries sting. They did the hard part of positioning themselves for the postseason, and now the question is whether the version of the team that earned that position will actually be available when the bracket starts.
Three things stand out.
- The margin for error shrinks fast. A team can survive one major offensive injury for a short stretch. Surviving two at once is different.
- LeBron James’ burden rises. Even without speculating on exact lineup decisions, the logic is obvious: when Dončić and Reaves are out or limited, James has to carry more creation and control.
- The first round may become the defining test. If Reaves is likely out for at least that stretch and Dončić is racing the clock, the Lakers may have to navigate the opening phase of the playoffs without the offensive balance they spent the season building.
That does not eliminate their chances. It does, however, shift the conversation from upside to durability and from matchups to recovery windows.
What to watch next
The next meaningful developments are not complicated.
First, watch whether Dončić’s treatment changes the Lakers’ public timeline or only their private optimism. Teams are often cautious with wording, especially around hamstring injuries. Any movement from “at least two weeks” toward a clearer return window would matter.
Second, watch whether the Lakers frame Reaves’ absence purely as a first-round issue or begin to speak in broader terms. A four-to-six-week estimate can cover very different realities depending on how a player progresses.
Third, pay attention to how the Lakers talk about function rather than dates. With injuries like these, the real question is not only when a player returns, but what he can do on return.
The uncomfortable truth for Los Angeles is that the postseason no longer starts from a place of accumulation. It starts from a place of triage. The Lakers still have star power, still have recent success, and still have a reason to believe they can be dangerous. But after April 2, their playoff path looks less like a climb and more like a medical countdown.
That is what makes these updates significant. They are not just bad injury news at a bad time. They change the terms of what the Lakers can reasonably hope to be when the games stop allowing excuses.